Health
Abortion Access Debate Heats Up
The debate over banning telehealth access to mifepristone for abortions intensifies, with one in four U.S. cases relying on this method.
Coverage timeline — 1 article
Scientific American
One in four abortions in the U.S. rely on telehealth access to mifepristone, but antiabortion activists want to ban it
2026-05-27 10:30 UTC